New Pilot Assessment and Recovery Centres could save hundreds of lives a year 

June 1, 2026

An additional 200 liver transplants could be carried out per year, if 15 pilot Assessment and Recovery Centres (ARC) set up by NHS Blood and Transplant are successful.  

Under the pilot scheme donated organs that might not otherwise have been transplanted are transferred to the specialist centres to have oxygenated fluids passed through them through via machine perfusion technology, meaning the liver can function during storage.  

This process creates critical extra time for clinicians to test and assess how well the organs work, so that more can be transplanted with confidence. In future, if the pilot is successful, organs would also receive ‘recovery’ interventions, such as surgical repairs, blood type changes, and cell therapies, further increasing the pool of transplantable organs. 

Pamela Healy, Chief Executive of the British Liver Trust said: “For patients and families affected by liver disease, the wait for a transplant can be an incredibly uncertain and anxious time. The launch of the ARCs liver pathway offers real hope by helping ensure more donated organs can be used safely and effectively. This innovative approach has the potential to significantly increase the number of liver transplants carried out each year, offering a second chance to many more people in urgent need.” 

The ARCs programme is funded and supported by the UK’s four departments of health, including the Department of Health and Social Care. The first three hospital trusts selected by NHS Blood and Transplant as liver pilot sites are Cambridge University Hospitals NHS Foundation Trust, Royal Free London NHS Foundation Trust, and King’s College Hospital NHS Foundation Trust. 

Derek Manas, NHS Blood and Transplant Medical Director for Organ and Tissue Donation and Transplantation, said: “The ARCs programme will ensure we truly honour the gift of donation by creating unique clinical facilities where precious donated organs can be sent to be evaluated and assessed for suitability to be transplanted. This will ensure more organs are available for transplant, increasing clinical confidence and increasing organ utilisation rates. 

“ARCs are part of the NHS’ wider ambition to reduce health inequalities and harness the latest innovations.  

“NHSBT’s national network and research capability means we’re well-placed to deliver this service, transforming organ transplantation – and saving more lives.” 

 

More news

Our Budget Case to the Treasury: Investing in Prevention

Our Budget Case to the Treasury: Investing in Prevention

The Autumn Budget on 28th October is a chance to prevent thousands of families from experiencing the devastating impact of liver disease. Because 90% of liver disease is preventable, government action on alcohol harm and obesity could ...
Liver UK helps shape new European recommendations on liver cancer surveillance

Liver UK helps shape new European recommendations on liver cancer surveillance

A major new paper published in The Lancet Regional Health – Europe has highlighted the challenges of detecting liver cancer earlier across Europe and sets out practical lessons from countries around the world to improve surveillance ...
The LIVERAGE research studies

The LIVERAGE research studies

The LIVERAGE and LIVERAGE Cirrhosis studies are large clinical research studies for adults living with MASLD, a type of fatty liver disease. These studies focus on people with MASH, a more advanced form of MASLD.  The studies include ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.